India Office
Established in November 2008, the Office of Global Policy and Strategy's (OGPS) India Office (INO) serves as the lead FDA on-site presence in New Delhi, India. The India Office addresses operational and policy matters concerning FDA-regulated products in collaboration with the Government of India counterparts. In line with the FDA's mission, the INO's primary focus is ensuring the safety, quality, and effectiveness of food and medical products exported to the United States.
The India Office advances the FDA's mission to protect and promote public health by:
- Conducting commodity-specific inspections to meet the requirements of FDA-specific legislative mandates;
- Building strong coalitions and partnerships with regulatory authorities, industry, academia, multilateral organizations, non-governmental organizations, and other relevant institutions to increase the FDA’s understanding of India’s regulatory framework and processes, and to share information about FDA science-based regulations and requirements;
- Enhancing FDA’s knowledge of India’s legal requirements and oversight capacity of India's regulatory agencies; Indian companies that manufacture or export products subject to the FDA’s jurisdiction; and emerging trends and issues of relevance to the FDA to ensure product safety and quality; and
- Expanding upon and building better quality data to inform the FDA’s regulatory decisions and actions.
Contact:
Gregory Smith, Director
Deputy Director (Vacant)
U.S. Food and Drug Administration
Office of Global Policy and Strategy
India Office
U.S. Embassy New Delhi
New Delhi, India
Tel: +91-11-2419-8269
E-mail: US-FDA-INO@fda.hhs.gov
Focus on India
India is one of the largest exporters of drugs and biologics to the United States, as measured by FDA import lines. The country is also a global leader in the export of shrimp and spices.
- FDA India Office Addresses Herbal and Ayurvedic Products, From a Global Perspective, August 2024
- India’s Unique Opportunity and Important Responsibility as the Pharmacy to the World, FDA Voices, October 2023
- Doing the Needful During India's "Second Wave," From a Global Perspective, August 2021
Partnerships and Collaboration
- Confidentiality Commitment – Food
- FDA to Export Inspection Council of India, June 2016
- Export Inspection Council of India to FDA, June 2016
- Memorandum of Understanding - Medical Products Safety, (Indefinite)
- Memorandum of Understanding – Food Safety, March 2015
- Statement of Intent – Cooperation on Medical Products, February 2014
- FDA’s International Partnership Focus Areas